Glaxo Loses Appeal For Asthma Inhaler Color Trademark In EU

Law360, London (September 9, 2020, 4:21 PM BST) -- A European court rejected an attempt by a subsidiary of GlaxoSmithKline PLC on Wednesday to register a trademark for a shade of the color purple — the hue of the pharmaceutical giant's asthma inhalers — saying it lacked "inherent distinctive character."

The court said in its ruling on GlaxoSmithKline that colors are inherently distinctive only in "exceptional circumstances." (AP Photo/Kirsty Wigglesworth)) The General Court of the European Union backed earlier decisions by the European Union Intellectual Property Office and its board of appeal. They held that Glaxo's use of the color was more "descriptive" than distinguishing, despite the company's evidence that consumers...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!